Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical modelFrancesco Alessandrini, Paolo Malatesta, Laura Menotti et al.|Oncogene|2019Cited by 78
Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human GlioblastomaIrene Appolloni, Paolo Malatesta, Francesca Piaggio et al.|Viruses|2021Cited by 11